chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Narrative:  70 yo male with chronic COPD, OSA, T2DM, cognitive impairment,  carcinoma of colon, BPH, depression, and Parkinson's disease reported having increased SOB with the second dose of Moderna (given 4/1/2021). First dose received 3/4/2021. Per medical record, patient reported increased shortness of  breath one day after second Moderna dose. Stated he normally requires 3L continuous O2. The day after second dose, reported he "turned up my concentrator to 4L and suffered through the day." Also states he initiated home action plan, but  only took 1 of the two medications (either prednisone or doxycycline, record did not specify). Patient not sure if it was the steroid or antibiotic. Oxygen requirements went back to normal by third day and shortness of breath returned to  baseline. Patient reported shortness of breath only lasted 1 day.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Narrative:  62 YO patient with PMH of HTN, HLD, CAD and DM reported mild shooting pain to R hand first and second digit following dose #1 of Covid-19 Pfizer vaccine, lasting two days. Pt reported this ADR when he returned for his second dose of COVID-19 VACCINE on 3/8/2021. Both doses were administered  without complications.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle twitching
Clinical narrative: Narrative: 44 YO male with PMH of anxiety, HTN, GERD, DM2, HLD, and PTSD reported abdominal twitching - started 48 hours after Pfizer COVID vaccine, first dose. Pt received first dose on 4/7/2021. At the time of reporting, pt received his second dose on 4/27/21. Both vaccine were administered without complications.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Peripheral swelling
Clinical narrative: swelling at injection site Narrative: Per supervisor report:  " stated right arm swollen after second immunization. ... She further stated that she was out four days with the first injection after having a fever."
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Unknown if patient passing away was due to COVID vaccine however, it is being reported as Vaccine Adverse Drug Event as the patient passed away within 42 days of receiving the vaccination.
Age: 90.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Endotracheal intubation, Loss of consciousness, Subdural haematoma
Clinical narrative: Narrative:  Pt is a 88y.o. male who died on 04/01/2021 w/ h/o AFib, BHP, malignant tumor of colon, HTN, GERD, aortic&mitral valve disorders. Pt received Moderna Covid-19 Vaccination 2/2 on 02/22/2021. Pt presented to ED on 03/31/2021 after being found unconscious at home. Examinations found pt had a catastrophic subdermal hematoma and was intubated. Pt's family decided to extubate, and pt died shortly after. Unlikely Moderna Covid-19 Vaccine caused/contributed to pt death.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia
Clinical narrative: Narrative: Veteran reported that she lost her voice two days after receiving the first dose and voice came back after 2 weeks and denied  any other symptoms now.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Death
Clinical narrative: Narrative:  Pt was a 96 YO male with PMH of CAD, bladder cancer, HTN, and HLD. Per medical record, pt passed away with COD of CHF.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative:  Pt is a 87y.o. male who died on 03/09/2021 w/ h/o HTN,HLD, BPH, Alzheimer's, Barret's esophagus, carotid occlusion, past hip fracture. Pt received Pfizer Covid-19 Vaccination 2/2 on 02/27/2021. Pt died while in hospice care. Unlikely that Pfizer Covid-19 vaccine caused/contributed to pt death.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Peripheral swelling
Clinical narrative: Headache, Myalgia,  Arm swelling Narrative:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Headache
Clinical narrative: Headache abdominal pain  Narrative:
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Injection site pain, Pyrexia
Clinical narrative: Fever CHILLS, SITE PAIN Narrative:
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Pt was a 75 YO male with PMH of cerebral infarction, vascular dementia, HTN, HLD, TIA, cardiomyopathy, and tobacco use. Facility was informed that pt had expired by agency.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Arteriosclerosis coronary artery, Asymptomatic bacteriuria, COVID-19 pneumonia
Clinical narrative: Narrative:  Pt is a 75y.o. male who died on 04/18/2021 w/ h/o CVA w/o residual deficits (2019), HLD, HTN, bradycardia, HTN, asthma, and PTSD. Pt received Modera Covid-19 Vaccination 1/2 on 03/15/2021. Pt presented to ED on 04/07/2021 reporting c/o soa x 3 days, gradually worsening, along with diarrhea x 1 day, and change in taste. He denied changes in smell or sick contacts. COVID test was negative on arrival. He was admitted for acute hypoxic respiratory failure 2/2 COVID variant vs other viral PNA vs bacterial PNA, hypokalemia, asymptomatic bacteriuria, and elevated transaminases. He developed acute anterior MI (too unstable for transfer to another Hospital, cardiac cath 4/13/21 notable for proximal LAD 90% calcified stenotic lesion, mid-LAD 60% stenotic segment), respiratory distress requiring intubation, hypotension (requiring pressor support), and AKI (requiring dialysis). Infectious disease is consulted, and recommended that a specimen be sent for genome sequencing to the state lab. Pt died while inpatient 04/18/2021 with physician reporting "Death was caused by: Combined septic and cardiogenic shock with multi-organ failure from suspected but not confirmed COVID infection". Unlikely that Moderna Covid-19 Vaccine caused/contributed to pt death.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiogenic shock, Catheterisation cardiac abnormal, Coronary artery stenosis, Death, Dialysis
Clinical narrative: Narrative:  Pt is a 75y.o. male who died on 04/18/2021 w/ h/o CVA w/o residual deficits (2019), HLD, HTN, bradycardia, HTN, asthma, and PTSD. Pt received Modera Covid-19 Vaccination 1/2 on 03/15/2021. Pt presented to ED on 04/07/2021 reporting c/o soa x 3 days, gradually worsening, along with diarrhea x 1 day, and change in taste. He denied changes in smell or sick contacts. COVID test was negative on arrival. He was admitted for acute hypoxic respiratory failure 2/2 COVID variant vs other viral PNA vs bacterial PNA, hypokalemia, asymptomatic bacteriuria, and elevated transaminases. He developed acute anterior MI (too unstable for transfer to another Hospital, cardiac cath 4/13/21 notable for proximal LAD 90% calcified stenotic lesion, mid-LAD 60% stenotic segment), respiratory distress requiring intubation, hypotension (requiring pressor support), and AKI (requiring dialysis). Infectious disease is consulted, and recommended that a specimen be sent for genome sequencing to the state lab. Pt died while inpatient 04/18/2021 with physician reporting "Death was caused by: Combined septic and cardiogenic shock with multi-organ failure from suspected but not confirmed COVID infection". Unlikely that Moderna Covid-19 Vaccine caused/contributed to pt death.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Endotracheal intubation, Hypokalaemia, Hypotension
Clinical narrative: Narrative:  Pt is a 75y.o. male who died on 04/18/2021 w/ h/o CVA w/o residual deficits (2019), HLD, HTN, bradycardia, HTN, asthma, and PTSD. Pt received Modera Covid-19 Vaccination 1/2 on 03/15/2021. Pt presented to ED on 04/07/2021 reporting c/o soa x 3 days, gradually worsening, along with diarrhea x 1 day, and change in taste. He denied changes in smell or sick contacts. COVID test was negative on arrival. He was admitted for acute hypoxic respiratory failure 2/2 COVID variant vs other viral PNA vs bacterial PNA, hypokalemia, asymptomatic bacteriuria, and elevated transaminases. He developed acute anterior MI (too unstable for transfer to another Hospital, cardiac cath 4/13/21 notable for proximal LAD 90% calcified stenotic lesion, mid-LAD 60% stenotic segment), respiratory distress requiring intubation, hypotension (requiring pressor support), and AKI (requiring dialysis). Infectious disease is consulted, and recommended that a specimen be sent for genome sequencing to the state lab. Pt died while inpatient 04/18/2021 with physician reporting "Death was caused by: Combined septic and cardiogenic shock with multi-organ failure from suspected but not confirmed COVID infection". Unlikely that Moderna Covid-19 Vaccine caused/contributed to pt death.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Multiple organ dysfunction syndrome, Myocardial infarction, Pneumonia bacterial, Pneumonia viral, Respiratory distress
Clinical narrative: Narrative:  Pt is a 75y.o. male who died on 04/18/2021 w/ h/o CVA w/o residual deficits (2019), HLD, HTN, bradycardia, HTN, asthma, and PTSD. Pt received Modera Covid-19 Vaccination 1/2 on 03/15/2021. Pt presented to ED on 04/07/2021 reporting c/o soa x 3 days, gradually worsening, along with diarrhea x 1 day, and change in taste. He denied changes in smell or sick contacts. COVID test was negative on arrival. He was admitted for acute hypoxic respiratory failure 2/2 COVID variant vs other viral PNA vs bacterial PNA, hypokalemia, asymptomatic bacteriuria, and elevated transaminases. He developed acute anterior MI (too unstable for transfer to another Hospital, cardiac cath 4/13/21 notable for proximal LAD 90% calcified stenotic lesion, mid-LAD 60% stenotic segment), respiratory distress requiring intubation, hypotension (requiring pressor support), and AKI (requiring dialysis). Infectious disease is consulted, and recommended that a specimen be sent for genome sequencing to the state lab. Pt died while inpatient 04/18/2021 with physician reporting "Death was caused by: Combined septic and cardiogenic shock with multi-organ failure from suspected but not confirmed COVID infection". Unlikely that Moderna Covid-19 Vaccine caused/contributed to pt death.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, Septic shock, Taste disorder, Transaminases increased
Clinical narrative: Narrative:  Pt is a 75y.o. male who died on 04/18/2021 w/ h/o CVA w/o residual deficits (2019), HLD, HTN, bradycardia, HTN, asthma, and PTSD. Pt received Modera Covid-19 Vaccination 1/2 on 03/15/2021. Pt presented to ED on 04/07/2021 reporting c/o soa x 3 days, gradually worsening, along with diarrhea x 1 day, and change in taste. He denied changes in smell or sick contacts. COVID test was negative on arrival. He was admitted for acute hypoxic respiratory failure 2/2 COVID variant vs other viral PNA vs bacterial PNA, hypokalemia, asymptomatic bacteriuria, and elevated transaminases. He developed acute anterior MI (too unstable for transfer to another Hospital, cardiac cath 4/13/21 notable for proximal LAD 90% calcified stenotic lesion, mid-LAD 60% stenotic segment), respiratory distress requiring intubation, hypotension (requiring pressor support), and AKI (requiring dialysis). Infectious disease is consulted, and recommended that a specimen be sent for genome sequencing to the state lab. Pt died while inpatient 04/18/2021 with physician reporting "Death was caused by: Combined septic and cardiogenic shock with multi-organ failure from suspected but not confirmed COVID infection". Unlikely that Moderna Covid-19 Vaccine caused/contributed to pt death.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Upper gastrointestinal haemorrhage
Clinical narrative: Narrative:  Pt is a 63y.o. male who died on 04/18/2021 w/ h/o DM, cirrhosis of liver, HTN, COPD, HLD, malignant of neoplasm of lung. Pt received Moderna Covid-19 Vaccination 1/2 on 04/06/2021. Pt presented to Hospital on 04/15/2021 w/ Acute upper GI bleed. Pt died inpatient on 04/18/2021. Unlikely that Moderna Covid-19 Vaccine caused/contributed to pt death.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Pt is a 91 YO male with PMH of OSA, dyspnea, EtOH abuse, HLD, HTN, sarcoidosis, and bradycardia. Facility was notified by agency of the patient's death.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  PATIENT RECEIVED ONE DOSE OF COVID VACCINE. PMH INCLUDES Parkinson Disease, mixed dementia, CVA with left sided hemiparesis, dysphagia, dysarthria. PATIENT WAS ACTIVELY DYING AND REQUIRED TRANSFER TO HOSPICE. NO OTHER CONCERNS RELATED TO DEATH OF PATIENT. REPORTING PER INSTRUCTIONS.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Pt was a 92 YO male seen by palliative care service with a PMH of tricuspid valve regurg, diastolic HF, pulmonary HTN, CKD, hypothyroidism, anemia, BPH, arrhythmia, HTN, and HLD. Per record system, agency was notified of pt's death by NOK.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Condition aggravated, Diarrhoea, Nausea, Pruritus
Clinical narrative: Narrative:  Pt received the first COVID-19 pfizer vaccine 3/5/2021. He experienced a rash with this first dose. After receiving the second vaccine, the rash became more prominent and worse x 10 days. The rash progressed from the lower extremities to the rest of the body with significant pruritus, abdominal discomfort, N/V, and diarrhea 4-5x daily. He received dexamethasone, diphenhydramine, and normal saline as stated above. He was discharged same day
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Vomiting
Clinical narrative: Narrative:  Pt received the first COVID-19 pfizer vaccine 3/5/2021. He experienced a rash with this first dose. After receiving the second vaccine, the rash became more prominent and worse x 10 days. The rash progressed from the lower extremities to the rest of the body with significant pruritus, abdominal discomfort, N/V, and diarrhea 4-5x daily. He received dexamethasone, diphenhydramine, and normal saline as stated above. He was discharged same day
Age: 90.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Death, Haematuria, Pain, Prostate cancer metastatic
Clinical narrative: Narrative: Pt is a 89y.o. male who died on 04/16/2021 w/ h/o DM, CVA, CKD-3 (bCr 1.8-2), CAD s/p CABG '08, OSA, HTN, HFpEF, aortic valve stenosis, Afib s/p pacer now on Eliquis, CG5 prostate cancer s/p XRT '19 now on total androgen blockade now with locally-advanced & metastatic castrate-resistant prostate cancer, LEFT hydroureteronephrosis 2/2 locally-advanced disease s/p silicone 6x26 stent 12/2020. Pt received Moderna Covid-19 Vaccination 2/2 on 02/19/2021. Pt presented to ED on 04/04/2021 with painful hematuria. Palliative care and patient admitted for hospice care 04/05/2021. Pt died inpatient on 04/16/2021 with physician reporting "Death was caused by: Metastatic prostate cancer complicated by acute renal failure". Unlikely that Moderna Covid-19 vaccine caused/contributed to pt death.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Pt is a 61 YO male with a PMH of cocaine abuse, atherosclerosis, OSA, HLD, HTN, cognitive impairment, and tobacco use. Pt's death was reported to facility by agency.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Death, General physical health deterioration
Clinical narrative: Narrative: Patient received two doses of covid vaccine. PMH of hx of Lung CA, BPH, HTN and g-tube for feedings. Patient was on HBPC and declined, refusing hospital care and requesting to go to hospice. No other details of death reported. reporting per instruction.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Haemoptysis, Mechanical ventilation, Metastases to liver, Nephrolithiasis
Clinical narrative: Narrative: Pt is a 75y.o. male who died on 04/16/2021 w/ h/o COPD, dementia, and HTN. Pt received Moderna Covid-19 vaccination 2/2 on 02/16/2021. Pt presented to ED on 4/15/2021 for Hemoptysis, kidney stone, Respiratory failure. Pt admitted with finding of hepatic metastases. Pt's family decided to take him off of the ventilator. Pt died inpatient on 04/16/2021. Unlikely that Moderna Covid-19 Vaccine caused/contributed to pt death.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Respiratory failure
Clinical narrative: Narrative: Pt is a 75y.o. male who died on 04/16/2021 w/ h/o COPD, dementia, and HTN. Pt received Moderna Covid-19 vaccination 2/2 on 02/16/2021. Pt presented to ED on 4/15/2021 for Hemoptysis, kidney stone, Respiratory failure. Pt admitted with finding of hepatic metastases. Pt's family decided to take him off of the ventilator. Pt died inpatient on 04/16/2021. Unlikely that Moderna Covid-19 Vaccine caused/contributed to pt death.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Pt is a78y.o. MALE who died on 05/07/2021 with a h/o dementia with behavioral disturbance, cerebrovascular disease, hyperlipidemia, hypertension. Pt receive Moderna Covid-19 Vaccination 1/2 on 03/27/2021. Pt died on 05/07/2021 at HOSPICE UNIT. Unlikely Moderna Covid-19 vaccine caused/contributed to pt death.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient received one dose of covid vaccine. PMH included ETOH abuse, CVA, afib on xarelto, CAD s/p MI, hyperlipidemia, chronic LE lymphedema, gout, Vit D deficiency, and colonic polyps (patient refuses colonoscopy). No documentation relating to cause of death. Reporting per instruction.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Pain
Clinical narrative: Narrative:  Pt is a 78y.o. male who died on 05/07/2021 w h/o bladder cancer, prostate cancer, metastatic malignant melanoma, hld, copd, cad, mitral valve replacement. Pt received Modern Covid-19 Vaccination 2/2 and 02/16/2021. Pt presented to ED with daughter on 04/22/2021 for pain control and increased level of care. Pt admitted with hospice consult, discharged to facility on 04/28/2021. Unlikely Moderna Covid-19 Vaccine caused/contributed to pt death.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Nausea, Ulcer haemorrhage, Vomiting
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pmh significant for cancer metastasis to liver, esophageal cancer stage IV, protein calories malnutrition, adrenal adenoma, renal cyst, fatty liver, hx of cerebrovascular accident, hypertension, t2dm, sleep apnea, hyperlipidemia, tobacco use. Pt was under the care of hospice at time of passing. Patient suffered ulcer bleed in January. Pt also suffered from nausea and vomiting before time of passing.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient received two doses of covid vaccine. Patient died three days after second dose. PMH includes T2DM (dx 1986), DM neuropathy, DM retinopathy, CKD stage 3, hx cervical spinal stenosis, hx recurrent UTIs, chronic PTSD and OSA (reports adherence w/ CPAP). Patient found deceased in home. No further reports of cause of death.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative: Pt is a 68y.o. male who died on 05/06/2021 w/ h/o COPD, CAD, T2DM, HLD, asthma, sleep apnea, depression, lung nodules, AFib, and obesity. Pt received Moderna Covid-19 Vaccination 2/2 on 4/28/2021. Pt died enroute (ambulance) to hospital on 05/06/2021. Unlikely Moderna Covid-19 vaccine caused/contributed to pt death.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Hyperkalaemia, Renal impairment
Clinical narrative: Narrative:  Patient received two covid vaccines. Patient died 3 weeks after second dose. Unclear if death was related to vaccine. PMH included stage IIIC (T3N3M0) adenocarcinoma of the R lung (s/p carboplatin, pretrexed, durcalumab, XRT), RA 2/2 durvalumab, PE with recurrent epicardial/pleural effusions s/p pericardial window, now c/b worsening renal function and hyperkalemia
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: Narrative:  Patient complained of a tickle in his throat following pfizer covid vaccination. Patient was observed and was no acute distress. Patient was able to leave without intervention.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count, Immune thrombocytopenia, Platelet count decreased, White blood cell count increased
Clinical narrative: Narrative: 70 YO male who received the Moderna COVID-19 vaccine on 1/27/21 and 2/23/21. Patient has a history of chronic lymphocytic leukemia. He was hospitalized at outside hospital on 3/2/21 with platelet count of 8, diagnosed with immune thrombocytopenia, and started on prednisone 60 mg daily. Per hematology/oncology provider, immune thrombocytopenia may have been associated with the COVID-19 vaccine. Eventually platelet counts returned to normal limits and prednisone was tapered.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: Narrative: Patient experienced symptoms of fever, muscle pain, and chills after both doses of the COVID-19 vaccine.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  No documentation found on chart review indicating that death was due to COVID-19 vaccine administration.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Narrative: Patient reported nausea following seconding dose of Pfizer COVID vaccine. Patient required no intervention, was in no acute distress, and was well enough to drive home.
Age: 98.0
Sex: M
Vaccine: VARZOS
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Flushing, Hyperhidrosis, Wheelchair user
Clinical narrative: Narrative:  Patient received a COVID-19 vaccine and <10 minutes after receiving the injection, patient complained of feeling like he is going to pass out and needed to lay down, feeling flush, mildly diaphoretic, weak, with sweaty hands. Wheelchair obtained and patient taken from exam room to lay down. Water given to patient and vitals obtained (see below vitals & time). Patient stated that he was at an ENT appointment earlier and his blood pressure was 150s/110s at the time of his appointment. 1550 BP 184/134, HR 126, O2 sat 98% 1605 BP 167/129, HR 109, O2 sat 100% 1620 BP 167/117, HR 88, O2 sat 100% 1640 BP 166/125, HR 87, O2 sat 100%
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary normal, Electrocardiogram, Fibrin D dimer increased, Flushing, Heart rate increased
Clinical narrative: Narrative:  Pt received first dose of Pfizer COVID-19 vaccine on 3/9 and developed almost immediate tachycardia, borderline high blood pressure, flushing. She was seen at hospital and fluid resuscitated along with labs, EKG. Her d-dimer was elevated in the 300s and had negative Duplex and CTA pulmonary angio to r/o PE. Records have been requested. Few days after vaccination, HR remained elevated 90-105 at rest, 115-130 walking, standing. mild fever has now resolved. Pt had history of COVID-19 with hospitalization and sepsis in 12/2020. Consults with Dr. suggests reaction is not anaphylaxis but a stronger reaction to the vaccine due to previous history of infection.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension, Laboratory test, Pyrexia, Tachycardia, Ultrasound Doppler normal
Clinical narrative: Narrative:  Pt received first dose of Pfizer COVID-19 vaccine on 3/9 and developed almost immediate tachycardia, borderline high blood pressure, flushing. She was seen at hospital and fluid resuscitated along with labs, EKG. Her d-dimer was elevated in the 300s and had negative Duplex and CTA pulmonary angio to r/o PE. Records have been requested. Few days after vaccination, HR remained elevated 90-105 at rest, 115-130 walking, standing. mild fever has now resolved. Pt had history of COVID-19 with hospitalization and sepsis in 12/2020. Consults with Dr. suggests reaction is not anaphylaxis but a stronger reaction to the vaccine due to previous history of infection.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Narrative: Patient experienced muscle pain and tenderness in the  arm/injection site after receiving the second COVID-19 dose. Symptoms resolved after taking Tylenol (unknown strength and duration).
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse event, Death
Clinical narrative: Narrative:  Unknown if death is related to vaccine, reporting as adverse event since it was within 42 days of receiving vaccination
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  asymptomatic positive test in fully vaccinated pt
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Malaise, SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient received J&J vaccine on 3/25/21 administered by PC staff. On 4/28/21 the patient self reported to an OSH for severe COVID-19 symptoms -- he tested positive at that time. Patient had ~5 day stay in outside hospital and is now home recovering
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Injection site erythema, Injection site pain, Injection site rash
Clinical narrative: Narrative: 4/21: Pain and soreness at injection site. Joint pain. 4/22: Soreness, chills and aches. 4/25: Rash and redness 4"x2" at injection site. 4/26: Rash and redness 6.5 x 3" at injection site.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Narrative: 4/21: Pain and soreness at injection site. Joint pain. 4/22: Soreness, chills and aches. 4/25: Rash and redness 4"x2" at injection site. 4/26: Rash and redness 6.5 x 3" at injection site.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Narrative: He notes having developed fever to 100.4F after the vaccination. The fever started on the evening of the vaccination and persisted for about 2x days prior to resolving. He started to treat it with acetaminophen on the day following development. He did not seek medical care and did not experience other common  adverse effects of the vaccination.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Injection site pain, Laboratory test, Neuralgia, Pain
Clinical narrative: Narrative:  Pt has Lt arm-,deltoid, Lt shoulder shooting/sharp pain- after 7 days of injection. Hand- 4 digit numbness everything excluding 5th digit. No visible injection mark- Pt pointed to distal deltoid region, posterior upper arm as location of injection. Injection might have not been given into deltoid but posterior/distal to that location. Labs, X-ray have been ordered- no results yet. Provider prescribed Gabapentin for nerve pain.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: Narrative:  Pt has Lt arm-,deltoid, Lt shoulder shooting/sharp pain- after 7 days of injection. Hand- 4 digit numbness everything excluding 5th digit. No visible injection mark- Pt pointed to distal deltoid region, posterior upper arm as location of injection. Injection might have not been given into deltoid but posterior/distal to that location. Labs, X-ray have been ordered- no results yet. Provider prescribed Gabapentin for nerve pain.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for End stage renal disease, peritoneal dialysis, renal allograft failure, nephrotic syndrome, t2dm, hyperlipidemia, overweight. No notation regarding cause of death or recent illness. Decreased 5/2/21.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Narrative: Patient reported mild tingling at the top of the head when they stood that resolved shortly thereafter. They required no intervention and were able to go home without assistance.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary mass, Discharge, Tenderness
Clinical narrative: Narrative:  Patient experienced a marble-sized lump in the right axilla and tenderness after receiving the COVID-19 vaccine in the right deltoid. It was reported that the lump did not have a head to it but was draining clear fluid.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Narrative: Patient developed lightheadness shortly after 1st dose of Pfizer covid vaccine. Resolved within 10 minutes with no  intervention.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea, Nausea, Vomiting
Clinical narrative: Narrative: She developed nausea about 45 minutes after the initial vaccination,  which lasted for about 1-1.5 hours prior to spontaneously resolving. It was not associated with vomiting, abdominal cramping or diarrhea. After resolution, she was able to tolerate oral (both food/liquid) intake.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for abnormal lung field, PVD, DM, coronary arteriosclerosis, ckd, hyperlipidemia. Pt received care outside the facility, and no notation regarding death or any recent illness.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pruritus
Clinical narrative: Narrative:  Patient reported slight itch at site of injection of Pfizer covid vaccine. Patient required no intervention and was able to leave on their own.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Blood chloride normal, Blood creatinine normal, Blood glucose normal, Blood potassium normal, Blood sodium normal
Clinical narrative: Narrative: About five minutes after being administered the Covid vaccine, during the 15 minute observation period, patient was noted to be unresponsive and hypotensive, BP 87/52, blood glucose of 92. He was taken to ED. It was determined by the ED physician to be vasovagal syncope, neurogenic syncope. Patient was administered one liter of IV fluid and observed for one hour. Checked CBC and Chemistries which were normal. Blood pressure returned to 118/67 and patient had returned to baseline, he felt well, was discharged from ED to return home. Patient reported while in ED he had a similar episode after administration of another vaccine about 15 years ago.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Blood urea normal, Carbon dioxide normal, Eosinophil percentage, Full blood count normal, Glomerular filtration rate decreased
Clinical narrative: Narrative: About five minutes after being administered the Covid vaccine, during the 15 minute observation period, patient was noted to be unresponsive and hypotensive, BP 87/52, blood glucose of 92. He was taken to ED. It was determined by the ED physician to be vasovagal syncope, neurogenic syncope. Patient was administered one liter of IV fluid and observed for one hour. Checked CBC and Chemistries which were normal. Blood pressure returned to 118/67 and patient had returned to baseline, he felt well, was discharged from ED to return home. Patient reported while in ED he had a similar episode after administration of another vaccine about 15 years ago.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Haematocrit normal, Haemoglobin normal, Hypotension, Immature granulocyte percentage increased, Lymphocyte count
Clinical narrative: Narrative: About five minutes after being administered the Covid vaccine, during the 15 minute observation period, patient was noted to be unresponsive and hypotensive, BP 87/52, blood glucose of 92. He was taken to ED. It was determined by the ED physician to be vasovagal syncope, neurogenic syncope. Patient was administered one liter of IV fluid and observed for one hour. Checked CBC and Chemistries which were normal. Blood pressure returned to 118/67 and patient had returned to baseline, he felt well, was discharged from ED to return home. Patient reported while in ED he had a similar episode after administration of another vaccine about 15 years ago.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphocyte percentage increased, Mean cell haemoglobin concentration normal, Mean cell haemoglobin increased, Mean cell volume normal, Mean platelet volume normal
Clinical narrative: Narrative: About five minutes after being administered the Covid vaccine, during the 15 minute observation period, patient was noted to be unresponsive and hypotensive, BP 87/52, blood glucose of 92. He was taken to ED. It was determined by the ED physician to be vasovagal syncope, neurogenic syncope. Patient was administered one liter of IV fluid and observed for one hour. Checked CBC and Chemistries which were normal. Blood pressure returned to 118/67 and patient had returned to baseline, he felt well, was discharged from ED to return home. Patient reported while in ED he had a similar episode after administration of another vaccine about 15 years ago.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Monocyte percentage increased, Neutrophil count, Neutrophil percentage, Platelet count normal, Red blood cell count normal
Clinical narrative: Narrative: About five minutes after being administered the Covid vaccine, during the 15 minute observation period, patient was noted to be unresponsive and hypotensive, BP 87/52, blood glucose of 92. He was taken to ED. It was determined by the ED physician to be vasovagal syncope, neurogenic syncope. Patient was administered one liter of IV fluid and observed for one hour. Checked CBC and Chemistries which were normal. Blood pressure returned to 118/67 and patient had returned to baseline, he felt well, was discharged from ED to return home. Patient reported while in ED he had a similar episode after administration of another vaccine about 15 years ago.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Red cell distribution width normal, Syncope, Unresponsive to stimuli, White blood cell count normal
Clinical narrative: Narrative: About five minutes after being administered the Covid vaccine, during the 15 minute observation period, patient was noted to be unresponsive and hypotensive, BP 87/52, blood glucose of 92. He was taken to ED. It was determined by the ED physician to be vasovagal syncope, neurogenic syncope. Patient was administered one liter of IV fluid and observed for one hour. Checked CBC and Chemistries which were normal. Blood pressure returned to 118/67 and patient had returned to baseline, he felt well, was discharged from ED to return home. Patient reported while in ED he had a similar episode after administration of another vaccine about 15 years ago.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Narrative: Patient report lightheadedness following administration of first dose of Pfizer vaccine. Patient was observed and then able to leave with no intervention.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Mental status changes
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for malignant tumor urinary bladder, dementia, anemia, neoplasm of kidney, gout, hyperlipidemia, ckd stage 3, essential htn, poor diabetic control, hydronephrosis, copd. Presented to ED 3/6/21 for altered mental status. Placed on hospice care in April. Pt was 86 years of age at time of death.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for hematuria, copd, malignant neoplasm of transverse colon, HTN, malignant neoplasm of lymph nodes, hx of antineoplastic chemotherapy. Pt received care at outside entity. No note on recent illness or cause of death.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Arthralgia, Dizziness, Ear discomfort, Gait disturbance
Clinical narrative: Narrative: 03/08 COVID vaccine dose #1 03/09: Pt reported experiencing dizziness since yesterday, reports left ear feels clogged, dizziness, headache, abdominal and joint pain at level (8)."Pt seen in non-Facility Er. 03/15: Pt reported that while in ER, found to have vertigo and vomiting for 8-9 hours, high blood pressure 170/102, can't walk without tipping, slightly nauseous of and off high BP. left ear still plugged. found to have fluid in the ear and treated with prednisone, no antibiotic. hearing diminished due to clogging.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypertension, Middle ear effusion, Nausea, Vertigo
Clinical narrative: Narrative: 03/08 COVID vaccine dose #1 03/09: Pt reported experiencing dizziness since yesterday, reports left ear feels clogged, dizziness, headache, abdominal and joint pain at level (8)."Pt seen in non-Facility Er. 03/15: Pt reported that while in ER, found to have vertigo and vomiting for 8-9 hours, high blood pressure 170/102, can't walk without tipping, slightly nauseous of and off high BP. left ear still plugged. found to have fluid in the ear and treated with prednisone, no antibiotic. hearing diminished due to clogging.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Narrative: 03/08 COVID vaccine dose #1 03/09: Pt reported experiencing dizziness since yesterday, reports left ear feels clogged, dizziness, headache, abdominal and joint pain at level (8)."Pt seen in non-Facility Er. 03/15: Pt reported that while in ER, found to have vertigo and vomiting for 8-9 hours, high blood pressure 170/102, can't walk without tipping, slightly nauseous of and off high BP. left ear still plugged. found to have fluid in the ear and treated with prednisone, no antibiotic. hearing diminished due to clogging.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Injection site mass
Clinical narrative: Narrative: Patient reported abdominal pain and a softball sized lump on her right arm after receiving the first dose of the Moderna Covid-19 vaccine. The patient reports going to an outside ED in which the ED provider told her the reaction was related to the vaccine, The patient was instructed to take famotidine or loratadine to help decrease the local reaction.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Pain, Pain in extremity
Clinical narrative: Narrative: STATES FOR >1 WEEK HANDS AND ARMS HAVE BEEN SO SORE THAT HE CAN'T PICK UP THINGS WITH THEM.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Visual impairment
Clinical narrative: Narrative:
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH Significant for dementia, vitamin d deficiency, hypercholesterolemia, HTN. Pt was under the care of home health. No notes regarding death or recent illness. Pt was 88 years of age at time of death.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Alanine aminotransferase normal, Anion gap, Aspartate aminotransferase increased, Basophil count normal, Basophil percentage increased
Clinical narrative: Narrative:  Patient was hospitalized at hospital 5/8/2021 with severe hypokalemia after he completed labs the same day as his COVID 19 vaccination 5/7/2021. They hypokalemia was also present on previous labs in 12/2020. ADR being submitted related to time association with Vaccine only.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Blood albumin decreased, Blood alkaline phosphatase increased, Blood bilirubin normal, Blood calcium normal, Blood chloride increased
Clinical narrative: Narrative:  Patient was hospitalized at hospital 5/8/2021 with severe hypokalemia after he completed labs the same day as his COVID 19 vaccination 5/7/2021. They hypokalemia was also present on previous labs in 12/2020. ADR being submitted related to time association with Vaccine only.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine normal, Blood glucose normal, Blood magnesium, Blood potassium decreased, Blood sodium normal
Clinical narrative: Narrative:  Patient was hospitalized at hospital 5/8/2021 with severe hypokalemia after he completed labs the same day as his COVID 19 vaccination 5/7/2021. They hypokalemia was also present on previous labs in 12/2020. ADR being submitted related to time association with Vaccine only.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Blood urea decreased, Carbon dioxide normal, Condition aggravated, Eosinophil count decreased, Eosinophil percentage decreased
Clinical narrative: Narrative:  Patient was hospitalized at hospital 5/8/2021 with severe hypokalemia after he completed labs the same day as his COVID 19 vaccination 5/7/2021. They hypokalemia was also present on previous labs in 12/2020. ADR being submitted related to time association with Vaccine only.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Glomerular filtration rate normal, Haematocrit decreased, Haemoglobin decreased, Hypokalaemia, Lymphocyte count decreased
Clinical narrative: Narrative:  Patient was hospitalized at hospital 5/8/2021 with severe hypokalemia after he completed labs the same day as his COVID 19 vaccination 5/7/2021. They hypokalemia was also present on previous labs in 12/2020. ADR being submitted related to time association with Vaccine only.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphocyte percentage decreased, Mean cell haemoglobin concentration normal, Mean cell haemoglobin increased, Mean cell volume normal, Mean platelet volume normal
Clinical narrative: Narrative:  Patient was hospitalized at hospital 5/8/2021 with severe hypokalemia after he completed labs the same day as his COVID 19 vaccination 5/7/2021. They hypokalemia was also present on previous labs in 12/2020. ADR being submitted related to time association with Vaccine only.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic function test, Monocyte count, Monocyte percentage increased, Neutrophil count, Neutrophil percentage increased
Clinical narrative: Narrative:  Patient was hospitalized at hospital 5/8/2021 with severe hypokalemia after he completed labs the same day as his COVID 19 vaccination 5/7/2021. They hypokalemia was also present on previous labs in 12/2020. ADR being submitted related to time association with Vaccine only.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Platelet count normal, Protein total normal, Red blood cell count, Red cell distribution width increased, White blood cell count normal
Clinical narrative: Narrative:  Patient was hospitalized at hospital 5/8/2021 with severe hypokalemia after he completed labs the same day as his COVID 19 vaccination 5/7/2021. They hypokalemia was also present on previous labs in 12/2020. ADR being submitted related to time association with Vaccine only.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMh significant for dyspnea, pulmonary fibrosis, AF, pacemaker, asthma, hyperlipidemia, aortic incompetence, chf, aortic valve stenosis, overweight, fibrosis of lungs, pulmonary hypertension. Deceased 4/30/2021. No cause of death noted, no notation regarding recent illness. Seen in March 26th for SOB upon waking up.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc). for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH Significant for abnormal ecg, dementia, obesity, basal cell carcinoma. PT was 70 years of age. Pt was in a LTC nursing home per note 01/2021. Received most care at outside entity. No notation regarding cause of death, or any recent illnesses.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Narrative: Patient received 2nd vaccine at an outside facility  on 04/20/21 and reported N/V since getting vaccination.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Death, General physical health deterioration
Clinical narrative: Narrative:  Patent was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there ADR that occurred between the observation period and the date of death. PMH Significant for multiple myeloma, cervical myelopathy, Hepatocellular carcinoma, hx of hepatitis c, ckd, anemia, hyperlipidemia, lung nodules, essential htn, hepatocellular carcinoma. Was under the care of palliative care and hospice. He decompensated in april and placed into hospice.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling cold, Paraesthesia
Clinical narrative: Narrative: approx 5 minutes after vaccine administration, pt reported feeling tingling in arms and sensation of cold, "like a cool breeze". Symptoms lasted approx 1 minute then resolved. He denied other symptoms. Provided pt with water, monitored VS. Observed for additional 15 minutes. Pt reported all symptoms had resolved and he wished to return home.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Injection site reaction, Injection site warmth, Rash erythematous
Clinical narrative: Narrative: She developed ~2-3in x 2-3 in well circumscribed rectangular erythematous rash over the injection site about 7 days afterwards. This was additional described as warm to touch and indurated. It Persisted for about w prior to spontaneously resolving. No therpaies were tried or complieted
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Migraine, Nausea, Vomiting
Clinical narrative: Narrative:  She has a PMH significant for migraines and developed a migraine a/w nausea/vomiting about 5-6 hours after the initial injection. The issues  persisted for about another 2x days prior to resolving. While she is on maintenance rx for migraines, she did not take any abortive rx as she was unsure if this was ok in the setting of vaccination. She went to see her private PCP last week and was provided with the advice to take her maintenance rx prior to vaccination. Discussed common side effects of COVID vaccination and discussed when to week care. Noted that this vaccination has triggered migraines for others.  Reviewed taking currently prescribed abortive rx and potentially already prescribed anti-nausea rx and when to take depending on how she does after this vaccination.